239 related articles for article (PubMed ID: 7835119)
21. The value of urinary steroid analysis in chorionic neoplasia.
Kodama M; Totani R; Kodama T
Am J Obstet Gynecol; 1977 Mar; 127(6):628-37. PubMed ID: 190888
[TBL] [Abstract][Full Text] [Related]
22. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
Cole LA; Tanaka A; Kim GS; Park SY; Koh MW; Schwartz PE; Chambers JT; Nam JH
Gynecol Oncol; 1996 Feb; 60(2):264-70. PubMed ID: 8631549
[TBL] [Abstract][Full Text] [Related]
23. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
Kanda K
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
[TBL] [Abstract][Full Text] [Related]
24. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
van Cromvoirt SM; Thomas CM; Quinn MA; McNally OM; Bekkers RL
Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
[TBL] [Abstract][Full Text] [Related]
25. UGP in urogenital disorders: Egyptian experience.
el-Ahmady O; Halim AB; Gad M; Walker R
Anticancer Res; 1996; 16(4B):2301-8. PubMed ID: 8694560
[TBL] [Abstract][Full Text] [Related]
26. The biochemical properties of urinary human chorionic gonadotropin from the patients with trophoblastic disease.
Nishimura R; Endo Y; Tanabe K; Ashitaka Y; Tojo S
J Endocrinol Invest; 1981; 4(3):349-58. PubMed ID: 7320438
[TBL] [Abstract][Full Text] [Related]
27. [Urinary hCG excretion patterns of patients with chorionic tumor during chemotherapy: indication of remission by chemotherapy].
Isojima S; Koyama K; Kamata T; Naka O; Kushiki N
Nihon Naibunpi Gakkai Zasshi; 1973 Dec; 49(12):1424-35. PubMed ID: 4359526
[No Abstract] [Full Text] [Related]
28. Urinary gonadotropin fragment (UGF) measurements in the diagnosis and management of ovarian cancer.
Cole LA; Nam JH
Yale J Biol Med; 1989; 62(4):367-78. PubMed ID: 2596125
[TBL] [Abstract][Full Text] [Related]
29. hCG, its free subunits and its metabolites. Roles in pregnancy and trophoblastic disease.
Cole LA
J Reprod Med; 1998 Jan; 43(1):3-10. PubMed ID: 9475142
[TBL] [Abstract][Full Text] [Related]
30. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
[TBL] [Abstract][Full Text] [Related]
31. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
[TBL] [Abstract][Full Text] [Related]
32. Immobilized Datura stramonium agglutinin column chromatography, a novel method to discriminate the urinary hCGs of patients with invasive mole and choriocarcinoma from those of normal pregnant women and patients with hydatidiform mole.
Endo T; Iino K; Nozawa S; Iizuka R; Kobata A
Jpn J Cancer Res; 1988 Feb; 79(2):160-4. PubMed ID: 3130349
[TBL] [Abstract][Full Text] [Related]
33. The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG.
Cole LA; Kardana A; Andrade-Gordon P; Gawinowicz MA; Morris JC; Bergert ER; O'Connor J; Birken S
Endocrinology; 1991 Sep; 129(3):1559-67. PubMed ID: 1714836
[TBL] [Abstract][Full Text] [Related]
34. Separation of nicked human chorionic gonadotropin (hCG), intact hCG, and hCG beta fragment from standard reference preparations and raw urine samples.
Birken S; Chen Y; Gawinowicz MA; Lustbader JW; Pollak S; Agosto G; Buck R; O'Connor J
Endocrinology; 1993 Sep; 133(3):1390-7. PubMed ID: 7689955
[TBL] [Abstract][Full Text] [Related]
35. The hCG assay in the treatment of trophoblastic disease.
Pattillo RA; Hussa RO
J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
[TBL] [Abstract][Full Text] [Related]
36. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
37. [Role of hysteroscopy in diagnosis and management of trophoblastic disease].
Suzuki A; Kawaguchi K; Konishi I; Ida K; Fujii S; Matsuura S
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):255-60. PubMed ID: 6321615
[TBL] [Abstract][Full Text] [Related]
38. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
39. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
[TBL] [Abstract][Full Text] [Related]
40. [Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer].
Nishimura R; Kobayashi K; Katsuno M; Kobayashi T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):143-8. PubMed ID: 1690253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
